Viewing StudyNCT00002442



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00002442
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02

Brief Title: A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs
Sponsor: Glaxo Wellcome
Organization: NIH AIDS Clinical Trials Information Service

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
Anti-HIV Agents View
Drug Therapy Combination View
Zidovudine View
Drug Administration Schedule View
Stavudine View
HIV Protease Inhibitors View
Lamivudine View
Indinavir View
Dosage Forms View
Nelfinavir View
Reverse Transcriptase Inhibitors View